These results suggest that CD153-CpG vaccination improves obesity-induced metabolic disorders, such as glucose tolerance and insulin resistance, and does not have severe adverse events such as weight loss and loss of appetite. The gene discussed is TNFSF8; the disease is obesity disorder.